193 related articles for article (PubMed ID: 32854138)
1. Calcium channel blockers, survival and ischaemic stroke in patients with dementia: a Swedish registry study.
Kalar I; Xu H; Secnik J; Schwertner E; Kramberger MG; Winblad B; von Euler M; Eriksdotter M; Garcia-Ptacek S
J Intern Med; 2021 Apr; 289(4):508-522. PubMed ID: 32854138
[TBL] [Abstract][Full Text] [Related]
2. Statins, Risk of Death and Ischemic Stroke in Patients with Dementia: A Registry-Based Observational Cohort Study.
Petek B; Xu H; Villa-Lopez M; Winblad B; Kramberger MG; Eriksdotter M; Garcia-Ptacek S
Curr Alzheimer Res; 2020; 17(10):881-892. PubMed ID: 33327915
[TBL] [Abstract][Full Text] [Related]
3. Calcium-Channel Blockers and Dementia Risk in Older Adults - National Health Insurance Service - Senior Cohort (2002-2013).
Hwang D; Kim S; Choi H; Oh IH; Kim BS; Choi HR; Kim SY; Won CW
Circ J; 2016 Oct; 80(11):2336-2342. PubMed ID: 27666598
[TBL] [Abstract][Full Text] [Related]
4. Comparison of amlodipine versus other calcium channel blockers on blood pressure variability in hypertensive patients in China: a retrospective propensity score-matched analysis.
Zhang L; Yang J; Li L; Liu D; Xie X; Dong P; Lin Y
J Comp Eff Res; 2018 Jul; 7(7):651-660. PubMed ID: 29888950
[TBL] [Abstract][Full Text] [Related]
5. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
Yamada H; Suga N; Maeda K; Kimura Y; Miura N; Futenma A; Imai H
Arzneimittelforschung; 2010; 60(2):64-70. PubMed ID: 20329653
[TBL] [Abstract][Full Text] [Related]
6. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
7. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.
Colbourne L; Harrison PJ
Mol Psychiatry; 2022 Sep; 27(9):3904-3912. PubMed ID: 35618884
[TBL] [Abstract][Full Text] [Related]
8. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
[TBL] [Abstract][Full Text] [Related]
9. Amlodipine treatment of hypertension associates with a decreased dementia risk.
Feldman L; Vinker S; Efrati S; Beberashvili I; Gorelik O; Wasser W; Shani M
Clin Exp Hypertens; 2016; 38(6):545-9. PubMed ID: 27392121
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
Cheng KH; Cheng KC; Cheng KY; Yang YH; Lee CW; Lai WT
Curr Med Res Opin; 2017 Jun; 33(6):1111-1117. PubMed ID: 28300435
[TBL] [Abstract][Full Text] [Related]
11. Amlodipine and cardiovascular outcomes in hypertensive patients: meta-analysis comparing amlodipine-based versus other antihypertensive therapy.
Lee SA; Choi HM; Park HJ; Ko SK; Lee HY
Korean J Intern Med; 2014 May; 29(3):315-24. PubMed ID: 24851066
[TBL] [Abstract][Full Text] [Related]
12. A randomised controlled trial of calcium channel blockade (CCB) with Amlodipine For the treatment oF subcortical ischaEmic vasCular demenTia (AFFECT): study protocol.
Greenan C; Murphy L; Yu LM; Kehoe PG; Coulthard E; Bath P; Stewart R; Jones R; Corbett A; Thomas A; Connelly P; Arrojo F; Canning R; Wallach S; Henderson C; McGuinness B; O'Sullivan M; Holmes C; Knapp M; Ballard C; Passmore P;
Trials; 2016 Jul; 17(1):324. PubMed ID: 27430267
[TBL] [Abstract][Full Text] [Related]
13. No Significant Difference in Cognitive Decline and Mortality between Parkinson's Disease Dementia and Dementia with Lewy Bodies: Naturalistic Longitudinal Data from the Swedish Dementia Registry.
Fereshtehnejad SM; Lökk J; Wimo A; Eriksdotter M
J Parkinsons Dis; 2018; 8(4):553-561. PubMed ID: 30103351
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
Lee YC; Lin CH; Wu RM; Lin JW; Chang CH; Lai MS
PLoS One; 2014; 9(6):e98961. PubMed ID: 24910980
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
da Silva PM
Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular Diseases in ~30,000 Patients in the Swedish Dementia Registry.
Cermakova P; Johnell K; Fastbom J; Garcia-Ptacek S; Lund LH; Winblad B; Eriksdotter M; Religa D
J Alzheimers Dis; 2015; 48(4):949-58. PubMed ID: 26402118
[TBL] [Abstract][Full Text] [Related]
17. Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke.
Rothwell PM; Howard SC; Dolan E; O'Brien E; Dobson JE; Dahlöf B; Poulter NR; Sever PS;
Lancet Neurol; 2010 May; 9(5):469-80. PubMed ID: 20227347
[TBL] [Abstract][Full Text] [Related]
18. Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry.
Fereshtehnejad SM; Damangir S; Cermakova P; Aarsland D; Eriksdotter M; Religa D
Alzheimers Res Ther; 2014; 6(5-8):65. PubMed ID: 25478027
[TBL] [Abstract][Full Text] [Related]
19. Delayed Decline of Cognitive Function by Antihypertensive Agents: A Cohort Study Linked with Genotype Data.
Sternberg Z; Podolsky R; Yu J; Tian M; Hojnacki D; Schaller B
J Prev Alzheimers Dis; 2022; 9(4):679-691. PubMed ID: 36281672
[TBL] [Abstract][Full Text] [Related]
20. Use of calcium-channel blockers in pediatric renal transplant recipients.
Silverstein DM; Palmer J; Baluarte HJ; Brass C; Conley SB; Polinsky MS
Pediatr Transplant; 1999 Nov; 3(4):288-92. PubMed ID: 10562973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
